PetMed Express (NASDAQ:PETS) Releases Earnings Results, Misses Estimates By $0.01 EPS

PetMed Express (NASDAQ:PETS) released its earnings results on Tuesday. The company reported ($0.19) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.01), FiscalAI reports. The firm had revenue of $42.82 million for the quarter, compared to the consensus estimate of $52.00 million. PetMed Express had a negative return on equity of 70.81% and a negative net margin of 35.51%.

PetMed Express Stock Performance

PetMed Express stock traded down $0.04 during mid-day trading on Tuesday, reaching $2.13. The company’s stock had a trading volume of 167,206 shares, compared to its average volume of 91,789. The company has a market capitalization of $45.54 million, a price-to-earnings ratio of -0.70 and a beta of 0.77. PetMed Express has a 12 month low of $1.57 and a 12 month high of $4.32. The business’s 50 day simple moving average is $2.27 and its 200 day simple moving average is $2.61.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the stock. Zacks Research upgraded shares of PetMed Express to a “hold” rating in a report on Thursday, April 30th. Weiss Ratings restated a “sell (d-)” rating on shares of PetMed Express in a report on Tuesday, May 12th. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Reduce”.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of PETS. Steel Partners Holdings L.P. acquired a new position in shares of PetMed Express in the 4th quarter valued at approximately $620,000. Federated Hermes Inc. grew its holdings in shares of PetMed Express by 30.1% during the 4th quarter. Federated Hermes Inc. now owns 627,743 shares of the company’s stock valued at $2,009,000 after purchasing an additional 145,357 shares during the last quarter. Bridgeway Capital Management LLC grew its holdings in shares of PetMed Express by 164.3% during the 3rd quarter. Bridgeway Capital Management LLC now owns 107,816 shares of the company’s stock valued at $271,000 after purchasing an additional 67,016 shares during the last quarter. CIBC Bancorp USA Inc. bought a new stake in shares of PetMed Express during the 3rd quarter valued at approximately $153,000. Finally, UMB Bank n.a. bought a new stake in PetMed Express during the 4th quarter worth approximately $192,000. Institutional investors own 73.33% of the company’s stock.

PetMed Express Company Profile

PetMed Express, Inc operates as an online and catalog-based pet pharmacy and retail supplier under the 1-800-PetMeds brand name. The company distributes prescription and non‐prescription medications, nutritional supplements, flea and tick control products, and a range of pet health supplies directly to consumers. Through its licensed veterinary pharmacy in Delray Beach, Florida, PetMed Express fills orders for dogs, cats and other companion animals, offering both branded and generic products alongside its own private‐label formulations.

Founded in 1996 by Marc Puleo, PetMed Express built its business on the premise of convenience and cost savings for pet owners seeking reliable access to veterinary medications.